Why the Johnson & Johnson Vaccine Is Big News
Author Bio Full-time host of the Motley Fool Money radio show, MarketFoolery podcast, and other things. Part-time connoisseur of movies, basketball & fine bourbon. In this episode of MarketFoolery, host Chris Hill is joined by Motley fool analyst Jason Moser to discuss Johnson & Johnson's (NYSE:JNJ) one-shot vaccine getting the green light as the company prepares millions of doses to be deployed. Also, Netflix (NASDAQ:NFLX) cleans up at the Golden Globe Awards, while Disney (NYSE:DIS) has an opportunity to make a splash in April. Plus, we dip into the Fool Mailbag ...
Source: fool.com